Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H et al (2020) EuroGuiDerm Guideline on the systemic treatment of psoriasis vulgaris - part 1: treatment and monitoring recommendations. J Eur Acad Dermatol Venereol 34(11):2461–2498. https://doi.org/10.1111/jdv.16915

Article  CAS  PubMed  Google Scholar 

Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB et al (2022) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol 18(8):465–479. https://doi.org/10.1038/s41584-022-00798-0

Article  PubMed  PubMed Central  Google Scholar 

Gossec L, Kerschbaumer A, Ferreira RJO, Aletaha D, Baraliakos X, Bertheussen H et al (2024) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis 83(6):706–719. https://doi.org/10.1136/ard-2024-225531

Article  PubMed  Google Scholar 

Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19–34. https://doi.org/10.1136/ard-2022-223296

Article  PubMed  Google Scholar 

Uchida S, Oiso N, Komeda Y, Kudo M, Kawada A (2019) Paradoxical ulcerative colitis during treatment with secukinumab for psoriasis. Eur J Dermatol 29(4):444–445. https://doi.org/10.1684/ejd.2018.3391

Article  PubMed  Google Scholar 

Mössner R, Pinter A (2020) Paradoxical palmoplantar pustulosis induced by secukinumab and brodalumab: a report of three cases. Eur J Dermatol 30(2):177–178. https://www.jle.com/https://doi.org/10.1684/ejd.2020.3702

Article  Google Scholar 

Pirro F, Caldarola G, De Simone C, Moretta G, Giovanardi G, Peris K (2019) Multiple paradoxical reactions during ixekizumab therapy. Dermatol Ther 32(3):e12852. https://doi.org/10.1111/dth.12852

Article  PubMed  Google Scholar 

Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G (2008) Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 9(1):1–14. https://doi.org/10.2165/00128071-200809010-00001

Article  PubMed  Google Scholar 

Karamanakos A, Vergou T, Panopoulos S, Tektonidou MG, Stratigos AJ, Sfikakis PP (2021) Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy. Eur J Dermatol 31(3):307–317. https://doi.org/10.1684/ejd.2021.4056

Article  CAS  PubMed  Google Scholar 

Toussirot É, Aubin F (2016) Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open 2(2):e000239. https://doi.org/10.1136/rmdopen-2015-000239

Article  PubMed  PubMed Central  Google Scholar 

Hernández MV, Sanmartí R, Cañete JD, Descalzo MA, Alsina M, Carmona L, Gomez-Reino JJ, BIOBADASER 2.0 Study Group (2013) Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases. Arthritis Care Res (Hoboken) 65(12):2024–2031. https://doi.org/10.1002/acr.22096

Article  CAS  PubMed  Google Scholar 

Braun J, Baraliakos X, Listing J, Davis J, van der Heijde D, Haibel H et al (2007) Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 57(4):639–647. https://doi.org/10.1002/art.22669

Article  CAS  PubMed  Google Scholar 

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647. https://doi.org/10.1136/bmj.g7647

Article  PubMed  Google Scholar 

Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60–63. https://doi.org/10.1136/bmjebm-2017-110853

Article  PubMed  PubMed Central  Google Scholar 

Noell C, McQuade B, Gottlieb A, Rosmarin D (2017) Anti IL-17 flared psoriasis in a patient on secukinumab. Dermatol Ther 30(4). https://doi.org/10.1111/dth.12505

Martínez-Doménech Á, García-Legaz-Martínez M, Magdaleno-Tapial J, Giácaman M, Hernández-Bel P, Pérez-Ferriols A (2019) Paradoxical reversed plantar involvement during ixekizumab therapy for psoriasis. Dermatol Online J 25(4):14. https://doi.org/10.5070/D3254043589

Article  Google Scholar 

Sadik CD, Thieme M, Zillikens D, Terheyden P (2019) First emergence of pyoderma gangraenosum, palmoplantar pustulosis and sacroiliitis in a psoriasis patient associated with switching from secukinumab to brodalumab. J Eur Acad Dermatol Venereol 33(11):e406–e407. https://doi.org/10.1111/jdv.15714

Article  CAS  PubMed  Google Scholar 

Saylam Kurtipek G, Zekey E, Tuncez Akyurek F, Akyurek M, Unal M (2020) Unusual relapse in a psoriasis patient receiving secukinumab: Linear psoriasis. Dermatol Ther 33(3):e13346. https://doi.org/10.1111/dth.13346

Article  PubMed  Google Scholar 

Abbruzzese A, Venerito V, Lopalco G, Fornaro M, Giannotta M, Iannone F (2020) Paradoxical pustular psoriasis in a patient with psoriatic arthritis on Secukinumab Treatment. J Clin Rheumatol 26(6):e208–e209. https://doi.org/10.1097/rhu.0000000000001076

Article  PubMed  Google Scholar 

Currado D, Margiotta D, Conforti C, Coppola R, Panasiti V, Afeltra A (2020) New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report. Scand J Rheumatol 49(1):75–76. https://doi.org/10.1080/03009742.2019.1594359

Article  CAS  PubMed  Google Scholar 

Durmaz K, Ataseven A, Ozer I (2020) Paradoxical plaque psoriasis due to secukinumab treatment in an ankylosing spondylitis patient. Dermatol Ther 33(4):e13504. https://doi.org/10.1111/dth.13504

Article  PubMed  Google Scholar 

Satoh M, Yamamoto T (2020) Secukinumab-induced palmar vesiculopustular eruption in a patient with psoriasis. Dermatol Ther 33(3):e13332. https://doi.org/10.1111/dth.13332

Article  PubMed  Google Scholar 

Hlaca N, Zagar T, Kastelan M, Brajac I, Prpic-Massari L (2021) Ixekizumab-induced paradoxical pustular reaction successfully treated with guselkumab. Clin Exp Dermatol 46(8):1572–1573. https://doi.org/10.1111/ced.14757

Article  CAS  PubMed  Google Scholar 

Dogra S, Bishnoi A, Narang T, Handa S (2019) Secukinumab-induced paradoxical pustular psoriasis. Clin Exp Dermatol 44(1):72–73. https://doi.org/10.1111/ced.13731

Article  CAS  PubMed  Google Scholar 

Takahashi H, Sato K, Takagi A, Iizuka H (2018) Brodalumab-induced palmar pustular eruption and joint swelling accompanied by muscle pains in two cases of psoriasis. J Dermatol 45(11):e325–e326. https://doi.org/10.1111/1346-8138.14463

Article  PubMed  Google Scholar 

Honma M, Nozaki H, Hayashi K, Iinuma S, Ishida-Yamamoto A (2019) Palmoplantar pustulosis emerged on a case of generalized pustular psoriasis successfully treated by secukinumab. J Dermatol 46(12):e468–e469. https://doi.org/10.1111/1346-8138.15082

Article  PubMed  Google Scholar 

Hosokawa Y, Hamada T, Ashida H, Ikeda M (2019) Effective treatment with guselkumab for psoriatic alopecia as paradoxical reaction. J Dermatol 46(8):e302–e303. https://doi.org/10.1111/1346-8138.14842

Article  PubMed  Google Scholar 

Prussick L, Noell C, Her M, Alomran A, Abudu M, Rosmarin D (2018) Two cases of anti-interleukin-17 flared psoriasis. J Am Acad Dermatol 79(3):AB305. https://doi.org/10.1016/j.jaad.2018.05.1203

Article  Google Scholar 

Oiwa T, Fujita M, Takase S, Nishimura Y, Ota M, Okada K, Tachibana T (2019) A case of Ixekizumab-induced psoriasiform eruption. Acta Derm Venereol 99(4):446–447. https://doi.org/10.2340/00015555-3138

Article  PubMed  Google Scholar 

Tan TL, Taglia L, Yazdan P (2021) Drug-induced psoriasiform alopecia associated with interleukin-17 inhibitor therapy. J Cutan Pathol 48(6):771–774. https://doi.org/10.1111/cup.13952

Article  PubMed  Google Scholar 

Tadiotto Cicogna G, Messina F, Nalotto L, Szekely S, Alaibac M (2019) Case Report: paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy. F1000Res 8:336. https://doi.org/10.12688/f1000research.18493.1